Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis
International Journal of Cardiology, 07/17/09
Eslick GD et al. – Fish oil supplementation produces a clinically significant dose–dependent reduction of fasting blood TG but not total, HDL or LDL cholesterol in hyperlipidemic subjects.
Related Articles
Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway
Arteriosclerosis, Thrombosis, and Vascular Biology, 10/20/09
Relevance Score: 82%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 80%
Stroke in HIV infection and AIDS
Expert Review of Cardiovascular Therapy, 10/16/09
Relevance Score: 80%
Emotional Changes in Men Treated With Sildenafil Citrate for Erectile Dysfunction a Double-Blind, Placebo-Controlled Clinical Trial
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 80%
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09
Relevance Score: 80%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications
Internal and Emergency Medicine, 12/09/09
Lipoprotein particle subclasses, cardiovascular disease and HIV infection
Atherosclerosis, 12/09/09
Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia
Atherosclerosis, 12/09/09
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Canadian Medical Association Journal, 12/09/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/08/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


